Does Wearing Hearing Aids Impact the Affective State of Older Adults With Hearing Loss in Their Daily Lives?
1 other identifier
interventional
35
1 country
1
Brief Summary
The proposed field trial will clarify the real-world effectiveness of HAs in remediating deficits in emotion processing for older adults with mild-to-moderate hearing loss. This study will employ a repeated reversal design to establish baseline affective state without HAs, when wearing amplification, and after HAs are removed. This study will triangulate self-report, behavioral, and physiological measures to capture nuances of emotional processing in the laboratory and in daily listening. Naturalistic stimuli will be used as it occurs in daily life to elicit emotional experiences, and ecological momentary assessment and commercially-available wearable sensors will be used to track changes in emotional state in daily listening. Anchoring real-world emotional experiences with controlled laboratory experiences will validate wearable sensors. Additionally, laboratory emotional stimuli will be related to real-world emotional experiences to establish the utility of laboratory stimuli in future studies. It is likely that benefits in emotional processing will have differential effects based on individual characteristics (such as degree of hearing loss, age, gender, cognitive ability, and personality), so participants will be analyzed according to larger groupings based on individual differences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 31, 2024
CompletedFirst Posted
Study publicly available on registry
February 8, 2024
CompletedFebruary 8, 2024
January 1, 2024
1.9 years
January 31, 2024
January 31, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Self-reported arousal
Arousal rating measured with the Self-assessment manikin (SAM)
Measured several times per day for 6 days in each arm of the study (ecological momentary assessment); and at a lab appointment on day 7; day 28; and day 35 of the trial.
Self-reported valence
Valence rating measured with the Self-assessment manikin (SAM)
Measured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.
Secondary Outcomes (10)
Self-reported task-load
Measured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.
Physiological arousal - heart rate
easured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.
Physiological arousal - respiration activity
easured several times per day for 6 days in each arm of the study (ecological momentary assessment) and at a lab appointment on day 7; day 28; and day 35 of the trial.
Physiological arousal - electrodermal responses
Day 7; day 28; and day 35 of the trial.
Physiological valence - electromyography
Day 7; day 28; and day 35 of the trial.
- +5 more secondary outcomes
Study Arms (3)
Baseline-Unaided
NO INTERVENTIONNo hearing aids.
Aided
EXPERIMENTALFitted with bilateral hearing devices.
Follow-up-Unaided
NO INTERVENTIONNo hearing aids.
Interventions
Three week trial while wearing bilateral hearing devices.
Eligibility Criteria
You may qualify if:
- Bilateral, uncomplicated, adult-onset mild-to-moderate hearing loss.
- No previous experience with hearing aids
- Fluent English speakers
- Have adequate literacy and cognitive competence to complete informed consent and required questionnaires with minimal assistance.
- Able to transport themselves to the data collection site and participate in the study without assistance from researchers.
You may not qualify if:
- History of otologic surgery or chronic middle or outer ear pathology
- Evidence of retrocochlear involvement
- Known psychiatric or neurologic disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Memphis
Memphis, Tennessee, 38152, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jani A Johnson, PhD
University of Memphis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2024
First Posted
February 8, 2024
Study Start
July 1, 2020
Primary Completion
June 1, 2022
Study Completion
June 1, 2022
Last Updated
February 8, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share